AES
49
-2
IRM
31
-10
DUK
55
3
WMT
60
-15
INTU
54
-9
INTC
36
-3
ICE
62
2
XYL
25
-35
DVN
47
7
XRAY
31
-13
ESS
47
8
EMC
76
22
BXP
38
-4
ROK
42
-20
R
62
-14
DHI
32
-3
CVS
33
-2
CMI
68
-5
EBAY
52
4
RF
63
-14
AES
49
-2
IRM
31
-10
DUK
55
3
WMT
60
-15
INTU
54
-9
INTC
36
-3
ICE
62
2
XYL
25
-35
DVN
47
7
XRAY
31
-13
ESS
47
8
EMC
76
22
BXP
38
-4
ROK
42
-20
R
62
-14
DHI
32
-3
CVS
33
-2
CMI
68
-5
EBAY
52
4
RF
63
-14
Financhill
Back

SPDR Portfolio Developed World ex-US ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Buy
60

SPDW
SPDR Portfolio Developed World ex-US ETF

Last Price:
$44.60
Seasonality Move:
-0.85%
Sell
50

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$111.83
Seasonality Move:
-13.08%
Buy
60
SPDR Portfolio Developed World ex-US ETF (SPDW) is a Buy

Is SPDR Portfolio Developed World ex-US ETF a Buy, Sell or Hold?

  • The current SPDR Portfolio Developed World ex-US ETF [SPDW] share price is $44.23. The Score for SPDW is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • SPDW is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Rhythm Pharmaceuticals, Inc. (RYTM) is a Sell

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.86. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPDW Stock Price Chart

What is SPDR Portfolio Developed World ex-US ETF's stock price today?

  • The SPDR Portfolio Developed World ex-US ETF share price today is $44.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPDW is experiencing selling pressure, which indicates risk of future bearish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $111.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

SPDW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.53 Buy
Relative Strength Index (14 RSI): 54.56 Buy
Chaikin Money Flow: -3873754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.02 - 44.5) Buy
Bollinger Bands (100): (41.6 - 43.9) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.92 Buy
Relative Strength Index (14 RSI): 57.01 Buy
Chaikin Money Flow: -264527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.99 - 110.55) Buy
Bollinger Bands (100): (94.91 - 108.39) Buy

SPDW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.46 Sell
20-day SMA: 43.81 Buy
50-day SMA: 43.58 Buy
200-day SMA: 40.62 Buy
8-day EMA: 9.83 Buy
20-day EMA: 4.21 Buy
50-day EMA: 1.73 Buy
200-day EMA: 0.44 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.83 Buy
20-day SMA: 106.87 Buy
50-day SMA: 105.94 Buy
200-day SMA: 82.62 Buy
8-day EMA: 24.86 Buy
20-day EMA: 10.65 Buy
50-day EMA: 4.39 Buy
200-day EMA: 1.11 Buy

SPDR Portfolio Developed World ex-US ETF Earnings Growth & SPDW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.

SPDR Portfolio Developed World ex-US ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):